Nonresponse to 18-month Lamivudine Monotherapy in Chronic Hepatitis B Patients with Dual Genotype B and C Infection and Acute Exacerbation

Nonresponse to 18-month Lamivudine Monotherapy in Chronic Hepatitis B Patients with Dual Genotype B and C Infection and Acute Exacerbation

Molecular epidemiologic studies have indicated the possible existence of mixed infection of different hepatitis B virus (HBV) genotypes in chronic hepatitis B (CH-B) carriers, but the effect of dual HBV genotype B and C infection on the efficacy of lamivudine therapy remains unclear. We report four...

Full description

Bibliographic Details
Main Authors: Ming-Jen Sheu, Ching-Yih Lin, Chi-Shu Sun, Hsing-Tao Kuo, Lok-Beng Koay, Chuan Lee
Format: Article
Language:English
Published: Elsevier 2006-01-01
Series:Journal of the Formosan Medical Association
Subjects:
acute exacerbation
chronic hepatitis B
dual genotype infection
hepatitis B virus
lamivudine therapy
sustained response
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664609601558

Internet

http://www.sciencedirect.com/science/article/pii/S0929664609601558

Similar Items